TOKYO -- The hunt for medicines and vaccines to halt the spread of coronavirus in China and other countries has sparked another search. Investors are eagerly seeking out companies that could develop and market treatments.
Stock markets in the U.S. and Asia have already seen flurries of excitement over companies that are either working on vaccines, or already produce medicines that may help patients infected with the virus. Some biotechnology companies have jumped in value, along with pharmaceuticals groups making retroviral drugs.
